In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Valeant pays $2.6bn in cash for Medicis

Executive Summary

In support of its pursuit to become a leader in the dermatology field, Valeant Pharmaceuticals International Inc. is scooping up fellow public pharmaco Medicis Pharmaceutical Corp. for $2.6bn in cash. Valeant is paying $44 per share, a 36% premium.
Deal Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Contract

Related Companies